| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |